Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03827694 · ClinicalTrials.gov registry record
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
A clinical trial of Pulmonary Invasive Fungal Infections and Pulmonary Invasive Aspergillosis, sponsored by Arkansas Children's Hospital Research Institute.
- Recruiting
- Registry status
- 400
- Enrollment target
- 20
- Study locations
NCT03827694: Recruiting study of Pulmonary Invasive Fungal Infections and Pulmonary Invasive Aspergillosis, sponsored by Arkansas Children's Hospital Research Institute.
NCT03827694 is a study of Pulmonary Invasive Fungal Infections and Pulmonary Invasive Aspergillosis that is actively recruiting participants, run by Arkansas Children's Hospital Research Institute. The registered enrollment target is 400 participants. The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03827694, a study of Pulmonary Invasive Fungal Infections and Pulmonary Invasive Aspergillosis, is actively recruiting participants, sponsored by Arkansas Children's Hospital Research Institute.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study will establish a non-invasive diagnostic approach and evaluate clinical outcomes for children at high-risk for pulmonary invasive fungal infection (PIFI).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Non-Invasive Testing for PIFI
Study Locations (20)
California
- Rady Children's Hospital, UCSD - La Jolla
- Children's Hospital of Orange County - Orange
- Lucile Packard Children's Hospital, Stanford University - Palo Alto
- University of California San Francisco, Benioff Children's Hospital - San Francisco
Illinois
- Ann & Robert H. Lurie Children's Hospital of Chicago - Chicago
- University of Chicago Medicine, Comer Children's - Chicago
Minnesota
- University of Minnesota Medical School - Minneapolis
- Children's Minnesota - Saint Paul
Missouri
- Children's Mercy - Kansas City
- The Washington University - St Louis
Arkansas
- Arkansas Children's Research Institute - Little Rock
Connecticut
- Yale University - New Haven
District of Columbia
- Children's National Hospital - Washington D.C.
Florida
- All Children's Research Institute - St. Petersburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2018-10-30 |
| Est. Completion | 2026-12-31 |
What NCT03827694 shows while recruiting
NCT03827694 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Pulmonary Invasive Fungal Infections appearing as the primary indexed condition, and to 1 intervention - of which Non-Invasive Testing for PIFI is the first listed.
NCT03827694 names 20 study sites across 14 states, led by California, Illinois, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03827694 about?
NCT03827694 is a clinical study titled "Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections". This study will establish a non-invasive diagnostic approach and evaluate clinical outcomes for children at high-risk for pulmonary invasive fungal infection (PIFI).
What is the current status of trial NCT03827694?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2018-10-30. Estimated completion is 2026-12-31.
What conditions does trial NCT03827694 study?
This clinical trial studies the following conditions: Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis.
What interventions are being tested in trial NCT03827694?
The interventions under investigation include: Non-Invasive Testing for PIFI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03827694?
This trial is sponsored by Arkansas Children's Hospital Research Institute, which has 97 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03827694 being conducted?
This trial has 20 study locations across Arkansas, California, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI